Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials
Abstract (See the Editorial Commentary by Clancy and Nguyen, on pages 1123–5.)
Background. Invasive candidiasis (IC) is an important healthcare-related infection, with …
Background. Invasive candidiasis (IC) is an important healthcare-related infection, with …
Echinocandin antifungal drugs
DW Denning - The Lancet, 2003 - thelancet.com
The echinocandins are large lipopeptide molecules that are inhibitors of β-(1, 3)-glucan
synthesis, an action that damages fungal cell walls. In vitro and in vivo, the echinocandins …
synthesis, an action that damages fungal cell walls. In vitro and in vivo, the echinocandins …
[HTML][HTML] ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
F Tissot, S Agrawal, L Pagano, G Petrikkos… - …, 2017 - ncbi.nlm.nih.gov
Abstract The European Conference on Infections in Leukemia (ECIL) provides
recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy …
recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy …
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients
Clin Microbiol Infect 2012; 18 (Suppl. 7): 19–37 Abstract This part of the EFISG guidelines
focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations …
focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations …
Guidelines for treatment of candidiasis
Candida species are the most common cause of fungal infections. Candida species produce
infections that range from non—life-threatening mucocutaneous illnesses to invasive …
infections that range from non—life-threatening mucocutaneous illnesses to invasive …
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann, J Garbino, D Pittet - The Lancet infectious diseases, 2003 - thelancet.com
A substantial proportion of patients become colonised with Candida spp during hospital
stay, but only few subsequently develop severe infection. Clinical signs of severe infection …
stay, but only few subsequently develop severe infection. Clinical signs of severe infection …
[HTML][HTML] Comparison of caspofungin and amphotericin B for invasive candidiasis
J Mora-Duarte, R Betts, C Rotstein… - … England Journal of …, 2002 - Mass Medical Soc
Background Caspofungin is an echinocandin agent with fungicidal activity against candida
species. We performed a double-blind trial to compare caspofungin with amphotericin B …
species. We performed a double-blind trial to compare caspofungin with amphotericin B …
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
J Perlroth, B Choi, B Spellberg - Medical mycology, 2007 - academic.oup.com
Invasive fungal infections are increasingly common in the nosocomial setting. Furthermore,
because risk factors for these infections continue to increase in frequency, it is likely that …
because risk factors for these infections continue to increase in frequency, it is likely that …
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
PG Pappas, JH Rex, J Lee, RJ Hamill… - Clinical Infectious …, 2003 - academic.oup.com
We conducted a prospective, multicenter observational study of adults (n= 1447) and
children (n= 144) with candidemia at tertiary care centers in the United States in parallel with …
children (n= 144) with candidemia at tertiary care centers in the United States in parallel with …
Invasive fungal infections: a review of epidemiology and management options
DA Enoch, HA Ludlam… - Journal of medical …, 2006 - microbiologyresearch.org
Fungi are increasingly recognised as major pathogens in critically ill patients. Candida spp.
and Cryptococcus spp. are the yeasts most frequently isolated in clinical practice. The most …
and Cryptococcus spp. are the yeasts most frequently isolated in clinical practice. The most …